Nobody buys the coverage.
Most other “peptide information” sites are sales funnels: the writeups exist to steer you to whatever the owner sells. Here, no vendor pays to be covered, rated, or recommended — and we’ll tell you plainly about the one commercial thing we do offer.
The pattern.
Most “free peptide dose calculator” sites are owned by — or affiliated with — an RUO peptide vendor. The math tool is the lead-gen mechanism: search brings you in for a calculator, vendor links convert you on the way out.
You can usually spot it within 30 seconds. Check the footer for “a [Vendor Name] resource.” Check the “Where to buy” sidebar. Check whether the dose recommendations conveniently match what their parent vendor sells.
The problem with that.
Three things bend when content lives downstream of a sales funnel:
- Coverage gap. Vendor-owned sites only meaningfully cover what the vendor sells. Anything outside the catalog gets a thin entry or none.
- Suppressed signals.Negative news — CRLs, safety re-analyses, retracted papers, withdrawn trials — gets quietly omitted when it would hurt the vendor’s margin. The MK-677 CHF re-analysis is a good test case. Search for it.
- Sourcing dishonesty.A US-RUO-affiliated site cannot acknowledge that the same molecules sell for 5–10× less from overseas raws. That would destroy their parent’s margin. So they pretend the gray market doesn’t exist.
What never touches the coverage.
None of these can buy a word of what we write, rate, or recommend:
- · Vendor partnerships that influence coverage
- · Pay-to-be-covered, pay-to-be-rated, or paid placement in a writeup
- · Affiliate / “buy here” links inside the content
- · Comped product or vials “for review”
- · Sponsored content, native ads, or display advertising
- · Telehealth or compounding-pharmacy referral fees
The writeups never name or link a specific vendor. We describe categories(US RUO reseller, 503A pharmacy, gray-market raws) so the coverage can’t double as a storefront.
The one thing we do sell — and it’s optional.
Reading is 100% free, forever. The only commercial thing here: when you join the email list, you can opt into occasional “vial deals” emails (tested peptides, as low as $14) from the team behind this site. You can leave that box unticked and still get everything. Untick it later in one click.
That offer lives in the inbox, never in the coverage. It does not change a rating, a dose, a safety call, or what we cover. That separation is the whole point — it’s why we can still tell you the gray market is cheaper, name the bad news, and refuse to pre-fill a dose we don’t trust.
What you can verify.
The site has zero outbound affiliate links. Inspect the URLs — every “where to buy” on the sourcing pages describes a categoryof vendor (US RUO reseller, 503A pharmacy, gray-market raws via Discord), never names a specific one. The names are deliberately omitted because the second we publish a name, we’re either endorsing them or driving them business.
Read the sourcing guide → and check for yourself.
The editorial promise.
We will surface safety signals even on peptides that show up in those deal emails. We will tell you the gray market is cheaper. We will tell you the $300/mo RUO vial is the same molecule as the $5/mo factory raw. We will tell you when a peptide has no human trial data and we refuse to pre-fill a dose for it.
None of this is brave. It’s just what an honest reference looks like — the coverage stays independent even though the lights are kept on by the deal emails.